ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sex Hormones API Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-4W17045
Home | Market Reports | Health| Reproductive Health
Global Sex Hormones API Market Research Report 2024
BUY CHAPTERS

Global Sex Hormones API Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-4W17045
Report
November 2025
Pages:168
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Symbiotec
Gonane Pharma
Aspen API
Gedeon Richter
Zhejiang Xianju Pharmaceutical
Humanwell Healthcare
Hunan Norchem Pharmaceutical
Zhejiang Xianju Xianle Pharmaceutical
Valdepharm (Fareva)

Sex Hormones API Market

The global Sex Hormones API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Sex hormone APIs are chemical raw materials for sex hormone drugs, including estrogen, progesterone and male hormones, such as estradiol, testosterone, progesterone, etc.
From a downstream perspective, Oral Preparations accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Sex Hormones API leading manufacturers including Pfizer, EUROAPI, GSK, Symbiotec, Valdepharm (Fareva), Gonane Pharma, Aspen API, Gedeon Richter, Zhejiang Xianju Pharmaceutical, Humanwell Healthcare, etc., dominate supply; the top five capture approximately % of global revenue, with Pfizer leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Sex Hormones API market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Sex Hormones API Market Report

Report Metric Details
Report Name Sex Hormones API Market
Segment by Type
  • Estrogens
  • Progestins
  • Androgens
Segment by Application
  • Oral Preparations
  • Topical Preparations
  • Injections
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Pfizer, EUROAPI, GSK, Symbiotec, Valdepharm (Fareva), Gonane Pharma, Aspen API, Gedeon Richter, Zhejiang Xianju Pharmaceutical, Humanwell Healthcare, Hunan Norchem Pharmaceutical, Zhejiang Xianju Xianle Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Sex Hormones API study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Sex Hormones API Market report?

Ans: The main players in the Sex Hormones API Market are Pfizer, EUROAPI, GSK, Symbiotec, Valdepharm (Fareva), Gonane Pharma, Aspen API, Gedeon Richter, Zhejiang Xianju Pharmaceutical, Humanwell Healthcare, Hunan Norchem Pharmaceutical, Zhejiang Xianju Xianle Pharmaceutical

What are the Application segmentation covered in the Sex Hormones API Market report?

Ans: The Applications covered in the Sex Hormones API Market report are Oral Preparations, Topical Preparations, Injections

What are the Type segmentation covered in the Sex Hormones API Market report?

Ans: The Types covered in the Sex Hormones API Market report are Estrogens, Progestins, Androgens

1 Study Coverage
1.1 Introduction to Sex Hormones API: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Sex Hormones API Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Estrogens
1.2.3 Progestins
1.2.4 Androgens
1.3 Market Segmentation by Application
1.3.1 Global Sex Hormones API Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Oral Preparations
1.3.3 Topical Preparations
1.3.4 Injections
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Sex Hormones API Revenue Estimates and Forecasts 2020-2031
2.2 Global Sex Hormones API Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Sex Hormones API Sales Estimates and Forecasts 2020-2031
2.4 Global Sex Hormones API Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Sex Hormones API Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Sex Hormones API Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Estrogens Market Size by Manufacturers
3.5.2 Progestins Market Size by Manufacturers
3.5.3 Androgens Market Size by Manufacturers
3.6 Global Sex Hormones API Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Sex Hormones API Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Sex Hormones API Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Sex Hormones API Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Sex Hormones API Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Sex Hormones API Sales and Revenue by Type (2020-2031)
6.4 North America Sex Hormones API Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Sex Hormones API Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Sex Hormones API Sales and Revenue by Type (2020-2031)
7.4 Europe Sex Hormones API Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Sex Hormones API Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Sex Hormones API Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Sex Hormones API Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Sex Hormones API Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Sex Hormones API Sales and Revenue by Type (2020-2031)
9.4 Central and South America Sex Hormones API Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Sex Hormones API Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Sex Hormones API Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Sex Hormones API Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Sex Hormones API Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Pfizer
11.1.1 Pfizer Corporation Information
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Sex Hormones API Product Models, Descriptions and Specifications
11.1.4 Pfizer Sex Hormones API Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Pfizer Sex Hormones API Sales by Product in 2024
11.1.6 Pfizer Sex Hormones API Sales by Application in 2024
11.1.7 Pfizer Sex Hormones API Sales by Geographic Area in 2024
11.1.8 Pfizer Sex Hormones API SWOT Analysis
11.1.9 Pfizer Recent Developments
11.2 EUROAPI
11.2.1 EUROAPI Corporation Information
11.2.2 EUROAPI Business Overview
11.2.3 EUROAPI Sex Hormones API Product Models, Descriptions and Specifications
11.2.4 EUROAPI Sex Hormones API Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 EUROAPI Sex Hormones API Sales by Product in 2024
11.2.6 EUROAPI Sex Hormones API Sales by Application in 2024
11.2.7 EUROAPI Sex Hormones API Sales by Geographic Area in 2024
11.2.8 EUROAPI Sex Hormones API SWOT Analysis
11.2.9 EUROAPI Recent Developments
11.3 GSK
11.3.1 GSK Corporation Information
11.3.2 GSK Business Overview
11.3.3 GSK Sex Hormones API Product Models, Descriptions and Specifications
11.3.4 GSK Sex Hormones API Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 GSK Sex Hormones API Sales by Product in 2024
11.3.6 GSK Sex Hormones API Sales by Application in 2024
11.3.7 GSK Sex Hormones API Sales by Geographic Area in 2024
11.3.8 GSK Sex Hormones API SWOT Analysis
11.3.9 GSK Recent Developments
11.4 Symbiotec
11.4.1 Symbiotec Corporation Information
11.4.2 Symbiotec Business Overview
11.4.3 Symbiotec Sex Hormones API Product Models, Descriptions and Specifications
11.4.4 Symbiotec Sex Hormones API Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 Symbiotec Sex Hormones API Sales by Product in 2024
11.4.6 Symbiotec Sex Hormones API Sales by Application in 2024
11.4.7 Symbiotec Sex Hormones API Sales by Geographic Area in 2024
11.4.8 Symbiotec Sex Hormones API SWOT Analysis
11.4.9 Symbiotec Recent Developments
11.5 Valdepharm (Fareva)
11.5.1 Valdepharm (Fareva) Corporation Information
11.5.2 Valdepharm (Fareva) Business Overview
11.5.3 Valdepharm (Fareva) Sex Hormones API Product Models, Descriptions and Specifications
11.5.4 Valdepharm (Fareva) Sex Hormones API Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Valdepharm (Fareva) Sex Hormones API Sales by Product in 2024
11.5.6 Valdepharm (Fareva) Sex Hormones API Sales by Application in 2024
11.5.7 Valdepharm (Fareva) Sex Hormones API Sales by Geographic Area in 2024
11.5.8 Valdepharm (Fareva) Sex Hormones API SWOT Analysis
11.5.9 Valdepharm (Fareva) Recent Developments
11.6 Gonane Pharma
11.6.1 Gonane Pharma Corporation Information
11.6.2 Gonane Pharma Business Overview
11.6.3 Gonane Pharma Sex Hormones API Product Models, Descriptions and Specifications
11.6.4 Gonane Pharma Sex Hormones API Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Gonane Pharma Recent Developments
11.7 Aspen API
11.7.1 Aspen API Corporation Information
11.7.2 Aspen API Business Overview
11.7.3 Aspen API Sex Hormones API Product Models, Descriptions and Specifications
11.7.4 Aspen API Sex Hormones API Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 Aspen API Recent Developments
11.8 Gedeon Richter
11.8.1 Gedeon Richter Corporation Information
11.8.2 Gedeon Richter Business Overview
11.8.3 Gedeon Richter Sex Hormones API Product Models, Descriptions and Specifications
11.8.4 Gedeon Richter Sex Hormones API Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 Gedeon Richter Recent Developments
11.9 Zhejiang Xianju Pharmaceutical
11.9.1 Zhejiang Xianju Pharmaceutical Corporation Information
11.9.2 Zhejiang Xianju Pharmaceutical Business Overview
11.9.3 Zhejiang Xianju Pharmaceutical Sex Hormones API Product Models, Descriptions and Specifications
11.9.4 Zhejiang Xianju Pharmaceutical Sex Hormones API Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Zhejiang Xianju Pharmaceutical Recent Developments
11.10 Humanwell Healthcare
11.10.1 Humanwell Healthcare Corporation Information
11.10.2 Humanwell Healthcare Business Overview
11.10.3 Humanwell Healthcare Sex Hormones API Product Models, Descriptions and Specifications
11.10.4 Humanwell Healthcare Sex Hormones API Sales, Price, Revenue and Gross Margin (2020-2025)
11.10.5 Humanwell Healthcare Recent Developments
11.11 Hunan Norchem Pharmaceutical
11.11.1 Hunan Norchem Pharmaceutical Corporation Information
11.11.2 Hunan Norchem Pharmaceutical Business Overview
11.11.3 Hunan Norchem Pharmaceutical Sex Hormones API Product Models, Descriptions and Specifications
11.11.4 Hunan Norchem Pharmaceutical Sex Hormones API Sales, Price, Revenue and Gross Margin (2020-2025)
11.11.5 Hunan Norchem Pharmaceutical Recent Developments
11.12 Zhejiang Xianju Xianle Pharmaceutical
11.12.1 Zhejiang Xianju Xianle Pharmaceutical Corporation Information
11.12.2 Zhejiang Xianju Xianle Pharmaceutical Business Overview
11.12.3 Zhejiang Xianju Xianle Pharmaceutical Sex Hormones API Product Models, Descriptions and Specifications
11.12.4 Zhejiang Xianju Xianle Pharmaceutical Sex Hormones API Sales, Price, Revenue and Gross Margin (2020-2025)
11.12.5 Zhejiang Xianju Xianle Pharmaceutical Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Sex Hormones API Industry Chain
12.2 Sex Hormones API Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Sex Hormones API Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Sex Hormones API Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Sex Hormones API Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Sex Hormones API Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
Symbiotec
Gonane Pharma
Aspen API
Gedeon Richter
Zhejiang Xianju Pharmaceutical
Humanwell Healthcare
Hunan Norchem Pharmaceutical
Zhejiang Xianju Xianle Pharmaceutical
Valdepharm (Fareva)
List of Tables
 Table 1. Global Sex Hormones API Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Sex Hormones API Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Sex Hormones API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Sex Hormones API Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Sex Hormones API Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Sex Hormones API Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Tons)
 Table 7. Global Sex Hormones API Sales by Region (2020-2025) & (Tons)
 Table 8. Global Sex Hormones API Sales by Region (2026-2031) & (Tons)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Sex Hormones API Sales by Manufacturers (2020-2025) & (Tons)
 Table 11. Global Sex Hormones API Sales Share by Manufacturers (2020-2025)
 Table 12. Global Sex Hormones API Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Sex Hormones API Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Sex Hormones API by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sex Hormones API as of 2024)
 Table 16. Global Sex Hormones API Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Sex Hormones API Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Kg)
 Table 18. Key Manufacturers Sex Hormones API Manufacturing Base and Headquarters
 Table 19. Global Sex Hormones API Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Sex Hormones API Sales by Type (2020-2025) & (Tons)
 Table 23. Global Sex Hormones API Sales by Type (2026-2031) & (Tons)
 Table 24. Global Sex Hormones API Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Sex Hormones API Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Sex Hormones API ASP by Type (2020-2031) & (US$/Kg)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Sex Hormones API Sales by Application (2020-2025) & (Tons)
 Table 29. Global Sex Hormones API Sales by Application (2026-2031) & (Tons)
 Table 30. Sex Hormones API High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Sex Hormones API Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Sex Hormones API Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Sex Hormones API ASP by Application (2020-2031) & (US$/Kg)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Sex Hormones API Growth Accelerators and Market Barriers
 Table 37. North America Sex Hormones API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Sex Hormones API Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Sex Hormones API Growth Accelerators and Market Barriers
 Table 40. Europe Sex Hormones API Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Sex Hormones API Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Sex Hormones API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Sex Hormones API Sales (Tons) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Sex Hormones API Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Sex Hormones API Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Sex Hormones API Investment Opportunities and Key Challenges
 Table 47. Central and South America Sex Hormones API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Sex Hormones API Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Sex Hormones API Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. Pfizer Corporation Information
 Table 51. Pfizer Description and Major Businesses
 Table 52. Pfizer Product Models, Descriptions and Specifications
 Table 53. Pfizer Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 54. Pfizer Sales Value Proportion by Product in 2024
 Table 55. Pfizer Sales Value Proportion by Application in 2024
 Table 56. Pfizer Sales Value Proportion by Geographic Area in 2024
 Table 57. Pfizer Sex Hormones API SWOT Analysis
 Table 58. Pfizer Recent Developments
 Table 59. EUROAPI Corporation Information
 Table 60. EUROAPI Description and Major Businesses
 Table 61. EUROAPI Product Models, Descriptions and Specifications
 Table 62. EUROAPI Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 63. EUROAPI Sales Value Proportion by Product in 2024
 Table 64. EUROAPI Sales Value Proportion by Application in 2024
 Table 65. EUROAPI Sales Value Proportion by Geographic Area in 2024
 Table 66. EUROAPI Sex Hormones API SWOT Analysis
 Table 67. EUROAPI Recent Developments
 Table 68. GSK Corporation Information
 Table 69. GSK Description and Major Businesses
 Table 70. GSK Product Models, Descriptions and Specifications
 Table 71. GSK Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 72. GSK Sales Value Proportion by Product in 2024
 Table 73. GSK Sales Value Proportion by Application in 2024
 Table 74. GSK Sales Value Proportion by Geographic Area in 2024
 Table 75. GSK Sex Hormones API SWOT Analysis
 Table 76. GSK Recent Developments
 Table 77. Symbiotec Corporation Information
 Table 78. Symbiotec Description and Major Businesses
 Table 79. Symbiotec Product Models, Descriptions and Specifications
 Table 80. Symbiotec Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 81. Symbiotec Sales Value Proportion by Product in 2024
 Table 82. Symbiotec Sales Value Proportion by Application in 2024
 Table 83. Symbiotec Sales Value Proportion by Geographic Area in 2024
 Table 84. Symbiotec Sex Hormones API SWOT Analysis
 Table 85. Symbiotec Recent Developments
 Table 86. Valdepharm (Fareva) Corporation Information
 Table 87. Valdepharm (Fareva) Description and Major Businesses
 Table 88. Valdepharm (Fareva) Product Models, Descriptions and Specifications
 Table 89. Valdepharm (Fareva) Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 90. Valdepharm (Fareva) Sales Value Proportion by Product in 2024
 Table 91. Valdepharm (Fareva) Sales Value Proportion by Application in 2024
 Table 92. Valdepharm (Fareva) Sales Value Proportion by Geographic Area in 2024
 Table 93. Valdepharm (Fareva) Sex Hormones API SWOT Analysis
 Table 94. Valdepharm (Fareva) Recent Developments
 Table 95. Gonane Pharma Corporation Information
 Table 96. Gonane Pharma Description and Major Businesses
 Table 97. Gonane Pharma Product Models, Descriptions and Specifications
 Table 98. Gonane Pharma Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 99. Gonane Pharma Recent Developments
 Table 100. Aspen API Corporation Information
 Table 101. Aspen API Description and Major Businesses
 Table 102. Aspen API Product Models, Descriptions and Specifications
 Table 103. Aspen API Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 104. Aspen API Recent Developments
 Table 105. Gedeon Richter Corporation Information
 Table 106. Gedeon Richter Description and Major Businesses
 Table 107. Gedeon Richter Product Models, Descriptions and Specifications
 Table 108. Gedeon Richter Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 109. Gedeon Richter Recent Developments
 Table 110. Zhejiang Xianju Pharmaceutical Corporation Information
 Table 111. Zhejiang Xianju Pharmaceutical Description and Major Businesses
 Table 112. Zhejiang Xianju Pharmaceutical Product Models, Descriptions and Specifications
 Table 113. Zhejiang Xianju Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 114. Zhejiang Xianju Pharmaceutical Recent Developments
 Table 115. Humanwell Healthcare Corporation Information
 Table 116. Humanwell Healthcare Description and Major Businesses
 Table 117. Humanwell Healthcare Product Models, Descriptions and Specifications
 Table 118. Humanwell Healthcare Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 119. Humanwell Healthcare Recent Developments
 Table 120. Hunan Norchem Pharmaceutical Corporation Information
 Table 121. Hunan Norchem Pharmaceutical Description and Major Businesses
 Table 122. Hunan Norchem Pharmaceutical Product Models, Descriptions and Specifications
 Table 123. Hunan Norchem Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 124. Hunan Norchem Pharmaceutical Recent Developments
 Table 125. Zhejiang Xianju Xianle Pharmaceutical Corporation Information
 Table 126. Zhejiang Xianju Xianle Pharmaceutical Description and Major Businesses
 Table 127. Zhejiang Xianju Xianle Pharmaceutical Product Models, Descriptions and Specifications
 Table 128. Zhejiang Xianju Xianle Pharmaceutical Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 129. Zhejiang Xianju Xianle Pharmaceutical Recent Developments
 Table 130. Key Raw Materials Distribution
 Table 131. Raw Materials Key Suppliers
 Table 132. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 133. Milestones in Production Technology Evolution
 Table 134. Distributors List
 Table 135. Market Trends and Market Evolution
 Table 136. Market Drivers and Opportunities
 Table 137. Market Challenges, Risks, and Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources


List of Figures
 Figure 1. Sex Hormones API Product Picture
 Figure 2. Global Sex Hormones API Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. Estrogens Product Picture
 Figure 4. Progestins Product Picture
 Figure 5. Androgens Product Picture
 Figure 6. Global Sex Hormones API Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 7. Oral Preparations
 Figure 8. Topical Preparations
 Figure 9. Injections
 Figure 10. Sex Hormones API Report Years Considered
 Figure 11. Global Sex Hormones API Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Sex Hormones API Revenue (2020-2031) & (US$ Million)
 Figure 13. Global Sex Hormones API Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 14. Global Sex Hormones API Revenue Market Share by Region (2020-2031)
 Figure 15. Global Sex Hormones API Sales (2020-2031) & (Tons)
 Figure 16. Global Sex Hormones API Sales (CAGR) by Region (2020-2031) (Tons)
 Figure 17. Global Sex Hormones API Sales Market Share by Region (2020-2031)
 Figure 18. Top 5 and Top 10 Manufacturers Sex Hormones API Sales Volume Market Share in 2024
 Figure 19. Global Sex Hormones API Revenue Market Share Ranking (2024)
 Figure 20. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 21. Estrogens Revenue Market Share by Manufacturer in 2024
 Figure 22. Progestins Revenue Market Share by Manufacturer in 2024
 Figure 23. Androgens Revenue Market Share by Manufacturer in 2024
 Figure 24. Global Sex Hormones API Sales Market Share by Type (2020-2031)
 Figure 25. Global Sex Hormones API Revenue Market Share by Type (2020-2031)
 Figure 26. Global Sex Hormones API Sales Market Share by Application (2020-2031)
 Figure 27. Global Sex Hormones API Revenue Market Share by Application (2020-2031)
 Figure 28. North America Sex Hormones API Sales YoY (2020-2031) & (Tons)
 Figure 29. North America Sex Hormones API Revenue YoY (2020-2031) & (US$ Million)
 Figure 30. North America Top 5 Manufacturers Sex Hormones API Sales Revenue (US$ Million) in 2024
 Figure 31. North America Sex Hormones API Sales Volume (Tons) by Type (2020- 2031)
 Figure 32. North America Sex Hormones API Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 33. North America Sex Hormones API Sales Volume (Tons) by Application (2020-2031)
 Figure 34. North America Sex Hormones API Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 35. US Sex Hormones API Revenue (2020-2031) & (US$ Million)
 Figure 36. Canada Sex Hormones API Revenue (2020-2031) & (US$ Million)
 Figure 37. Mexico Sex Hormones API Revenue (2020-2031) & (US$ Million)
 Figure 38. Europe Sex Hormones API Sales YoY (2020-2031) & (Tons)
 Figure 39. Europe Sex Hormones API Revenue YoY (2020-2031) & (US$ Million)
 Figure 40. Europe Top 5 Manufacturers Sex Hormones API Sales Revenue (US$ Million) in 2024
 Figure 41. Europe Sex Hormones API Sales Volume (Tons) by Type (2020-2031)
 Figure 42. Europe Sex Hormones API Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 43. Europe Sex Hormones API Sales Volume (Tons) by Application (2020-2031)
 Figure 44. Europe Sex Hormones API Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 45. Germany Sex Hormones API Revenue (2020-2031) & (US$ Million)
 Figure 46. France Sex Hormones API Revenue (2020-2031) & (US$ Million)
 Figure 47. U.K. Sex Hormones API Revenue (2020-2031) & (US$ Million)
 Figure 48. Italy Sex Hormones API Revenue (2020-2031) & (US$ Million)
 Figure 49. Russia Sex Hormones API Revenue (2020-2031) & (US$ Million)
 Figure 50. Asia-Pacific Sex Hormones API Sales YoY (2020-2031) & (Tons)
 Figure 51. Asia-Pacific Sex Hormones API Revenue YoY (2020-2031) & (US$ Million)
 Figure 52. Asia-Pacific Top 8 Manufacturers Sex Hormones API Sales Revenue (US$ Million) in 2024
 Figure 53. Asia-Pacific Sex Hormones API Sales Volume (Tons) by Type (2020- 2031)
 Figure 54. Asia-Pacific Sex Hormones API Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 55. Asia-Pacific Sex Hormones API Sales Volume (Tons) by Application (2020-2031)
 Figure 56. Asia-Pacific Sex Hormones API Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 57. Indonesia Sex Hormones API Revenue (2020-2031) & (US$ Million)
 Figure 58. Japan Sex Hormones API Revenue (2020-2031) & (US$ Million)
 Figure 59. South Korea Sex Hormones API Revenue (2020-2031) & (US$ Million)
 Figure 60. China Taiwan Sex Hormones API Revenue (2020-2031) & (US$ Million)
 Figure 61. India Sex Hormones API Revenue (2020-2031) & (US$ Million)
 Figure 62. Central and South America Sex Hormones API Sales YoY (2020-2031) & (Tons)
 Figure 63. Central and South America Sex Hormones API Revenue YoY (2020-2031) & (US$ Million)
 Figure 64. Central and South America Top 5 Manufacturers Sex Hormones API Sales Revenue (US$ Million) in 2024
 Figure 65. Central and South America Sex Hormones API Sales Volume (Tons) by Type (2021-2031)
 Figure 66. Central and South America Sex Hormones API Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 67. Central and South America Sex Hormones API Sales Volume (Tons) by Application (2020-2031)
 Figure 68. Central and South America Sex Hormones API Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 69. Brazil Sex Hormones API Revenue (2020-2025) & (US$ Million)
 Figure 70. Argentina Sex Hormones API Revenue (2020-2025) & (US$ Million)
 Figure 71. Middle East, and Africa Sex Hormones API Sales YoY (2020-2031) & (Tons)
 Figure 72. Middle East and Africa Sex Hormones API Revenue YoY (2020-2031) & (US$ Million)
 Figure 73. Middle East and Africa Top 5 Manufacturers Sex Hormones API Sales Revenue (US$ Million) in 2024
 Figure 74. Middle East and Africa Sex Hormones API Sales Volume (Tons) by Type (2021-2031)
 Figure 75. South America Sex Hormones API Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 76. Middle East and Africa Sex Hormones API Sales Volume (Tons) by Application (2020-2031)
 Figure 77. Middle East and Africa Sex Hormones API Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 78. GCC Countries Sex Hormones API Revenue (2020-2025) & (US$ Million)
 Figure 79. Turkey Sex Hormones API Revenue (2020-2025) & (US$ Million)
 Figure 80. Egypt Sex Hormones API Revenue (2020-2025) & (US$ Million)
 Figure 81. South Africa Sex Hormones API Revenue (2020-2025) & (US$ Million)
 Figure 82. Sex Hormones API Industry Chain Mapping
 Figure 83. Regional Sex Hormones API Manufacturing Base Distribution (%)
 Figure 84. Global Sex Hormones API Production Market Share by Region (2020-2031)
 Figure 85. Sex Hormones API Production Process
 Figure 86. Regional Sex Hormones API Production Cost Structure
 Figure 87. Channels of Distribution (Direct Vs Distribution)
 Figure 88. Bottom-up and Top-down Approaches for This Report
 Figure 89. Data Triangulation
 Figure 90. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Sex Hormone APIs Market Research Report 2024
Global Estradiol API Market Research Report 2025
Global Glucocorticoid API Market Research Report 2024
Global Estrogen API Market Research Report 2024
Global Estrogen and Progesterone API Market Research Report 2024
Global Bulk API Market Research Report 2024
Global Testosterone API Market Research Report 2025
Global Dopamine API Market Research Report 2025
Global Sex Hormones Market Research Report 2024
Global Adrenocortical Hormones API Market Research Report 2025
Global Levonorgestrel API Market Research Report 2024
Global Natural Conjugated Estrogens API Market Research Report 2024
Global Clomifene Citrate API Market Research Report 2024
Global Steroid Hormone API Market Research Report 2024
Steroid APIs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global β Estradiol API Market Research Report 2024
Global Hormonal Drugs Market Research Report 2025
Global Corticosteroid API Market Research Report 2025
Global Corticosteroids API Market Research Report 2025
Global Steroid Starting Material Market Research Report 2024

RELATED REPORTS

Global Foetal Skull Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-8G20187
Fri Nov 28 00:00:00 UTC 2025

Add to Cart

Global Anatomy Set Pregnancy Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-30J19782
Sat Nov 22 00:00:00 UTC 2025

Add to Cart

Global Embryo Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-39D19945
Sat Nov 22 00:00:00 UTC 2025

Add to Cart

Global Prostate Model Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-25M19897
Sat Nov 22 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions